The FDA has cleared the Elecsys pTau181 test as an aid in early detection of amyloid pathology in the primary care setting for adults aged 55 years and older presenting with signs, symptoms or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback